“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox
BoNT-A offers substantial therapeutic benefits for NLUTD and demonstrates greater effectiveness when used early; thus, it should be considered a first-line treatment option.
Authors
- Zhina Sadeghi (ORCID: https://orcid.org/0000-0002-7751-8719)
- Vada Andree Furlan
- Alyssa J. Kobayashi
Institutions
- University of California, Irvine (US)
Publication Details
- Journal
- Neurourology and Urodynamics
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/nau.70216
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases